Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays

Cancer Research

Volumn 62, Issue 12, 2002, Pages 3466-3476

  Bayani, Jane ^a,b   Brenton, James D ^a   Macgregor, Pascale F ^a   Beheshti, Ben ^a,b   Albert, Monique ^a   Nallainathan, Dhani ^a   Karaskova, Jana ^a   Rosen, Barry ^a   Murphy, Joan ^a   Laframboise, Stephanie ^a   Zanke, Brent ^a,b   Squire, Jeremy A ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; RIBOSOME PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; CHROMOSOME 3P; CHROMOSOME 8; CHROMOSOME ANALYSIS; CHROMOSOME MAP; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENE MAPPING; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPING; METAPHASE; OVARY CARCINOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTRAL KARYOTYPING;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; COHORT STUDIES; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; KARYOTYPING; MIDDLE AGED; NEOPLASM METASTASIS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS;

EID: 0037096870     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Ovarian cancer: Epidemiology, biology, and prognostic factors
2. Incidence of P53 and K-ras alterations in ovarian mucinous and serous tumors
3. Frequent PTEN/MMAC mutations in endometri-old but not serous or mucinous epithelial ovarian tumors
4. Prognostic impact of chromosome aberrations in ovarian cancer
5. Chromosome aberrations in 35 primary ovarian carcinomas
6. Simple numeric abnormalities as primary karyotype changes in ovarian carcinoma
7. Clonal chromosome abnormalities in 54 cases of ovarian carcinoma
8. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies
9. Band 1p36 abnormalities and t(1;17) in ovarian carcinoma
10. Cytogenetic studies in ovarian cancer
11. Cytogenetic studies of epithelial ovarian carcinoma
12. Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases
13. Chromosome abnormalities in ovarian adenocarcinoma: II. Prognostic impact of nonrandom chromosome abnormalities in 244 cases
14. Chromosome abnormalities in ovarian adenocarcinoma: III. Using breakpoint data to infer and test mathematical models for oncogenesis
15. Comparative genomic hybridization: Uses and limitations
16. Advances in the detection of chromosomal aberrations using spectral karyotyping
17. Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells
18. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas
19. Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: Extensive similarity except for a difference at chromosome 2q24-q32
20. Genetic analysis of ovarian germ cell tumors by comparative genomic hybridization
21. Analysis of ovarian borderline tumors using comparative genomic hybridization and fluorescence in situ hybridization
22. Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas
23. Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel
24. PIK3CA is implicated as an oncogene in ovarian cancer
25. Genetic analysis of early-versus late-stage ovarian tumors
26. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization
27. Use of a cDNA microarray to analyse gene expression patterns in human cancer
28. Identification by cDNA microarray of genes involved in ovarian carcinogenesis
29. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray
30. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer
31. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer
32. Coordinately up-regulated genes in ovarian cancer
33. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
34. Systematic variation in gene expression patterns in human cancer cell lines
35. Multicolor spectral karyotyping of human chromosomes
36. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
37. Cluster analysis and display of genome-wide expression patterns
38. Molecular portraits of human breast tumours
39. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays
40. Modes of DAPI banding and simultaneous in situ hybridization
41. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
42. Molecular classification of cutaneous malignant melanoma by gene expression profiling
43. Genomic-scale gene expression profiling of normal and malignant immune cells
44. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray
45. Development of a prostate cDNA microarray and statistical gene expression analysis package
46. Informatic selection of a neural crest-melanocyte cDNA set for microarray analysis
47. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses
48. DNA microarray technology: The anticipated impact on the study of human disease
49. Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: Correlation to clinicopathological variables
50. Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping
51. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer
52. Chromosome abnormalities in primary endometrioid ovarian carcinoma
53. Functional calcium-sensing receptor expression in ovarian surface epithelial cells
54. Expression of osteopontin messenger RNA by macrophages in ovarian serous papillary cystadenocarcinoma: A possible association with calcification of psammoma bodies
55. Metallothionein expression in epithelial ovarian cancer: Effect of chemotherapy and prognostic significance
56. Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays
57. Tumor surveillance: Expression of the transporter associated with antigen processing (TAP-1) in ex vivo human tumor samples and its elevation by in vitro treatment with 1FN-γ and TNF-α
58. Mechanisms of escape from CD8+ T-cell clones specific for the HER-2/neu proto-oncogene expressed in ovarian carcinomas: Related and unrelated to decreased MHC class I expression
59. Several genes encoding ribosomal proteins are overexpressed in prostate cancer cell lines: Confirmation of L7a and L37 overexpression in prostate cancer tissue samples
60. Cancer gene discovery using digital differential display
61. IGFBP-3 in epithelial ovarian carcinoma and its association with clinicopathological features and patient survival
62. In vitro growth inhibition of ovarian cancer cells by decorin: Synergism of action between decorin and carboplatin
63. Transforming growth factor β and p-21: Multiple molecular targets of decorin-mediated suppression of neoplastic growth